Volume 271, Number 36, Issue of September 6, 1996 pp. 21906-21913
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Structure-Function Relationship of Lipoprotein Lipase-mediated Enhancement of Very Low Density Lipoprotein Binding and Catabolism by the Low Density Lipoprotein Receptor
FUNCTIONAL IMPORTANCE OF A PROPERLY FOLDED SURFACE LOOP COVERING THE CATALYTIC CENTER

(Received for publication, February 5, 1996, and in revised form, June 18, 1996)

From the Departments of Medicine and Cell Biology, Baylor College of Medicine, Houston, Texas 77030

We examined the structure-function relationship of human lipoprotein lipase (hLPL) in its ability to enhance the binding and catabolism of very low density lipoproteins (VLDL) in COS cells. Untransfected COS cells did not bind to or catabolize normal VLDL. Expression of wild-type hLPL by transient transfection enhanced binding, uptake, and degradation of the VLDL (a property of LPL that we call bridge function). Heparin pretreatment and a monoclonal antibody ID7 that blocks LDL receptor-binding domain of apoE both inhibited binding, and apoE2/E2 VLDL from a Type III hyperlipidemic subject did not bind. However, LDL did not reduce ¹²⁵I-VLDL binding to the hLPL-expressing cells, whereas rabbit -VLDL was an effective competitor. By contrast, LDL reduced uptake and degradation of ¹²⁵I-VLDL to the same extent as excess unlabeled VLDL or -VLDL. These data suggest that binding occurs by direct interaction of VLDL with LPL but the subsequent catabolism of the VLDL is mediated by the LDL receptor. Mutant hLPLs that were catalytically inactive, S132A, S132D, as well as the partially active mutant, S251T, and S172G, gave normal enhancement of VLDL binding and catabolism, whereas the partially active mutant S172D had markedly impaired capacity for the process; thus, there is no correlation between bridge function and lipolytic activity. A naturally occurring genetic variant hLPL, S447Ter, has normal bridge function. The catalytic center of LPL is covered by a 21-amino acid loop that must be repositioned before a lipid substrate can gain access to the active site for catalysis. We studied three hLPL loop mutants (LPL-cH, an enzymatically active mutant with the loop replaced by a hepatic lipase loop; LPL-cP, an enzymatically inactive mutant with the loop replaced by a pancreatic lipase loop; and C216S/C239S, an enzymatically inactive mutant with the pair of Cys residues delimiting the loop substituted by Ser residues) and a control double Cys mutant, C418S/C438S. Two of the loop mutants (LPL-cH and LPL-cP) and the control double Cys mutant C418S/C438S gave normal enhancement of VLDL binding and catabolism, whereas the third loop mutant, C216S/C239S, was completely inactive. We conclude that although catalytic activity and the actual primary sequence of the loop of LPL are relatively unimportant (wild-type LPL loop and pancreatic lipase loops have little sequence similarity), the intact folding of the loop, flanked by disulfide bonds, must be maintained for LPL to express its bridge function.

This article has been cited by other articles:

				T. Morita Comparative sequence analysis of myosin heavy chain proteins from congeneric shallow- and deep-living rattail fish (genus Coryphaenoides) J. Exp. Biol., May 1, 2008; 211(9): 1362 - 1367. [Abstract] [Full Text] [PDF]

				J. Rip, M. C. Nierman, C. J. Ross, J. W. Jukema, M. R. Hayden, J. J.P. Kastelein, E. S.G. Stroes, and J. A. Kuivenhoven Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1236 - 1245. [Abstract] [Full Text] [PDF]

				J. Lee, C. S. Tan, K. S. Chia, C. E. Tan, S. K. Chew, J. M. Ordovas, and E. S. Tai The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption J. Lipid Res., June 1, 2004; 45(6): 1132 - 1139. [Abstract] [Full Text] [PDF]

				T. Chiba, T. Nakazawa, K. Yui, E. Kaneko, and K. Shimokado VLDL Induces Adipocyte Differentiation in ApoE-Dependent Manner Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1423 - 1429. [Abstract] [Full Text] [PDF]

				D. Goti, Z. Balazs, U. Panzenboeck, A. Hrzenjak, H. Reicher, E. Wagner, R. Zechner, E. Malle, and W. Sattler Effects of Lipoprotein Lipase on Uptake and Transcytosis of Low Density Lipoprotein (LDL) and LDL-associated alpha -Tocopherol in a Porcine in Vitro Blood-Brain Barrier Model J. Biol. Chem., August 2, 2002; 277(32): 28537 - 28544. [Abstract] [Full Text] [PDF]

				M. G. McCoy, G.-S. Sun, D. Marchadier, C. Maugeais, J. M. Glick, and D. J. Rader Characterization of the lipolytic activity of endothelial lipase J. Lipid Res., June 1, 2002; 43(6): 921 - 929. [Abstract] [Full Text] [PDF]

				Y. Shimo-Nakanishi, T. Urabe, N. Hattori, Y. Watanabe, T. Nagao, M. Yokochi, M. Hamamoto, and Y. Mizuno Polymorphism of the Lipoprotein Lipase Gene and Risk of Atherothrombotic Cerebral Infarction in the Japanese Stroke, July 1, 2001; 32(7): 1481 - 1486. [Abstract] [Full Text] [PDF]

				J. D. Medh, S. L. Bowen, G. L. Fry, S. Ruben, J. Hill, H. Wong, and D. A. Chappell Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoproteins in vitro J. Lipid Res., July 1, 1999; 40(7): 1263 - 1275. [Abstract] [Full Text]

				M. Lucas, P.-H. Iverius, D. K. Strickland, and T. Mazzone Lipoprotein Lipase Reduces Secretion of Apolipoprotein E from Macrophages J. Biol. Chem., May 16, 1997; 272(20): 13000 - 13005. [Abstract] [Full Text] [PDF]